Irwin Naturals, Inc (IWINQ) Fair Value & Analysis
Healthcare · US · Market cap $736K
Irwin Naturals, Inc
IWINQ · US
Fair value as of: Jul 19, 2026
From 6 valuation models · updated yesterday
Fair value updated Jul 19, 2026, revised from $9.26 to $0.2877 (−96.9%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range $0.2100 – $0.2100 · fair‑value band $0.1470 – $0.4278 · the $0.2100 price screens below the $0.2877 fair value. As of Jul 19, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Irwin Naturals, Inc (IWINQ) currently trades at $0.2100, while our model-based Fair Value estimate is $0.2877, implying the stock looks roughly 37.0% undervalued today. We read business quality at 40/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, Irwin Naturals, Inc generated revenue of $86.7M at a net margin of -23.5%. Revenue declined 13.4% year over year. It earns a return on equity of -85.6%. Net debt stands at $16.2M. Fundamentals as of Jul 19, 2026
Our scenario range runs from $0.1470 (bear case) to $0.4278 (bull case); at $0.2100, the current price sits within that range. The share trades near its 52-week high and 5% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 33% fair-value upside, at 37%, IWINQ screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 19, 2026. TTM = trailing twelve months.
About the company
Irwin Naturals, Inc. engages in the development and distribution of vitamins and other health supplements in the United States, Canada, and internationally. The company offers CBD oils, gummies, soft gels, CBD creams, balms and roll-ons, vitamins and supplements, topicals, and other products. It also operates mental health clinics. The company sells its products through health food stores and mass market retailers, as well as through e-commerce retailers. It offers its products under the Irwin Naturals and Nature's Secret brands. The company was formerly known as Datinvest International Ltd. Irwin Naturals, Inc. is headquartered in Los Angeles, California. On August 9, 2024, Irwin Naturals, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Central District of California.
Revenue & earnings trend
FY2020 – FY2022 · reported fiscal years
Irwin Naturals, Inc reported revenue of $89.5M in FY2022 versus $89.4M in FY2020, a compound +0.1%/yr. Reported net income was −$4.0M in FY2022.
Is IWINQ fairly valued? → Check now
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| JD Health International Inc JDHIY | $5.33 | $7.09 | +33% |
| Alibaba Health Information Technology Limited ALBBY | $8.56 | $6.91 | -19% |
| Raia Drogasil S.A RADL3 | R$17.76 | R$14.97 | -16% |
| Yifeng Pharmacy Chain Co 603939 | ¥20.91 | ¥22.00 | +5% |
| Clicks Group CLCGY | $28.55 | $41.54 | +45% |
| Sugi Holdings SGIPF | $16.29 | $32.19 | +98% |
| Corporativo Fragua, S.A. CGSBF | $29.66 | $40.69 | +37% |
| DaShenLin Pharmaceutical Group 603233 | ¥16.68 | ¥19.21 | +15% |
| Redcare Pharmacy NV RDC | €66.40 | €124.16 | +87% |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥11.74 | ¥10.57 | -10% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Irwin Naturals, Inc (IWINQ) undervalued?
What is the fair value of IWINQ?
What is the quality score of IWINQ?
What is the revenue of Irwin Naturals, Inc (IWINQ)?
What is the net profit margin of IWINQ?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Irwin Naturals, Inc analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.